| 國立臺灣大學 |
2008 |
vancomycin在使用持續性低效率血液透析過濾(SLEDD-f) 的病人之藥品動態學與劑量學研究
|
林欣儀; Lin, Shin-Yi |
| 中國醫藥大學 |
2006-12-23 |
Vancomycin引起之嗜中性白血球減少症
|
楊蕙菁; 鍾尚容; 潘美如; 林明薰; 鄞玉娟; 郭啟文* |
| 國家衛生研究院 |
2023 |
Vancomycin治療伊莉莎白菌之體外、動物、臨床效果，與殺菌作用機轉之探究
|
郭書辰 |
| 國立成功大學 |
2024-07-16 |
Vancomycin波谷濃度與急性腎損傷之間的風險因子研究
|
曾湘涵; Tseng, Siang-Han |
| 臺大學術典藏 |
2018-09-10T05:57:47Z |
Vandermonde-form preserving matrices and the generalized signal richness preservation problem
|
Su, B.; Vaidyanathan, P.P.; BORCHING SU |
| 臺大學術典藏 |
2022-08-19T00:20:57Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Cheng A.-L.; Meng R.; Chao Y.; Hsieh T.-Y.; Huang W.-T.; Hwang W.-S.; Yu C.-W.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; CHIUN HSU |
| 國立臺灣大學 |
2012 |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, Chiun; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii; 鄭安理; 許駿; 游治維 |
| 臺大學術典藏 |
2018-09-10T09:15:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, C. and Yang, T.-S. and Huo, T.-I. and Hsieh, R.-K. and Yu, C.-W. and Hwang, W.-S. and Hsieh, T.-Y. and Huang, W.-T. and Chao, Y. and Meng, R. and Cheng, A.-L.; Hsu, Chiun;Yang, Tsai-Sheng;Huo, Teh-Ia;Hsieh, Ruey-Kuen;Yu, Chih-Wei;Hwang, Wei-Shou;Hsieh, Tsai-Yuan;Huang, Wen-Tsung;Chao, Yee;Meng, Robin;Cheng, Ann-Lii; 鄭安理 ;許駿 ;游治維; CHIH-WEI YU; Hsu, Chiun; ANN-LII CHENG; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii |
| 臺大學術典藏 |
2020-04-10T12:51:14Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Chiun Hsu;Yang T.-S.;Huo T.-I.;Hsieh R.-K.;Yu C.-W.;Hwang W.-S.;Hsieh T.-Y.;Huang W.-T.;Chao Y.;Meng R.;Cheng A.-L.; Chiun Hsu; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L. |
| 臺大學術典藏 |
2020-07-09T02:57:03Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
CHIH-WEI YU; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; Hsu C. |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu C.; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; ANN-LII CHENG |
| 臺大學術典藏 |
2020-05-26T09:27:14Z |
Vandetanib plus pemetrexed for the second-line treatment of advanced non - small-cell lung cancer: A randomized, double-blind phase III trial
|
De Boer R.H;Arrieta ?;Chih-Hsin Yang;Gottfried M;Chan V;Raats J;De Marinis F;Abratt R.P;Wolf J;Blackhall F.H;Langmuir P;Milenkova T;Read J;Vansteenkiste J.F.; De Boer R.H; Arrieta ?; CHIH-HSIN YANG; Gottfried M; Chan V; Raats J; De Marinis F; Abratt R.P; Wolf J; Blackhall F.H; Langmuir P; Milenkova T; Read J; Vansteenkiste J.F. |
| 國立臺灣大學 |
2011 |
Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non- Small-Cell Lung Cancer: A Randomized, Double-Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Versus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (Nsclc): A Randomized, Double-Blind Phase Iii Trial (Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Vs Pemetrexed as 2nd-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (Nsclc); a Randomized, Double- Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pernetrexed Versus Pemetrexed as 2nd-Line Therapy in Patients with Advanced Nsclc: A Randomized, Double-Blind Phase Iii Trial ( Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 臺大學術典藏 |
2019-12-19T07:12:49Z |
Vane shear behavior of soft Bangkok clay
|
Seah, T. H.; Note, S. T.; Chan, I. C.; I-CHI CHAN |
| 國立臺灣科技大學 |
2014 |
VANET-based secure value-added services
|
Horng, S.-J.;Tzeng, S.-F. |
| 國立屏東大學 |
2012 |
VANET分層式網路架構路由研究
|
施釗德;林志勳;蔡承軒 |
| 國立臺中教育大學 |
2003 |
vanHiele幾何思考的評量方式比較與後設認知之研究
|
陳淑惠; Chen, Shu-Hui |
| 高雄醫學大學 |
1997 |
Vanidilol : a vanilloid type vasorlaxant and ocular hypotensive β-adrenoceptor blocker with partial β2 agonist activity
|
明木,吳炳男,何婉青,洪秀貞,陳雪君,林永哲,陳英俊 |
| 高雄醫學大學 |
1997 |
Vanidilol: a vanilloid type vasorlaxant and ocular hypotensive β-adrenoceptor block with partial β2 agonist activity
|
明木;吳炳男;何婉青;洪秀貞;陳 雪君;林永哲;陳英俊 |
| 高雄醫學大學 |
1997 |
Vanidilol: a vanilloid type vasorlaxant and ocular hypotensive β-adrenoceptor block with partial β2 agonist activity
|
許明木;吳炳男;何婉青;洪秀貞;陳 雪君;林永哲;陳英俊 |
| 高雄醫學大學 |
1997 |
Vanidilol: a vanilloid type vasorlaxant and ocular hypotensive β-adrenoceptor block with partial β2 agonist activity
|
許明木;吳炳男;何婉青;洪秀貞;雪君, 陳;林永哲;陳英俊 |
| 輔英科技大學 |
1997-04-01 |
Vanidilol: A Vanilloid-Type Vasorelaxant and Ocular Hypotensive Beta-Adrenoceptor Blocker with Partial Beta-2-Agonist Activity.
|
Min-Muh Sheu;Bin-Nan Wu;Wong-Ching Ho;Show-Jen Hong;Sheue-Jiun Chen;Young-Tso Lin;Ing-Jun Chen |
